Toru Takemura
-
- Atherosclerosis and Cardiovascular Diseases 2
-
- Chronic Kidney Disease and Diabetes 2
-
- Lipoproteins and Cardiovascular Health 2
-
- Adipokines, Inflammation, and Metabolic Diseases 2
- Influenza Virus Research Studies 1
-
- SARS-CoV-2 and COVID-19 Research 1
-
- Bone health and treatments 1
-
- Spectroscopy and Quantum Chemical Studies 1
- Co-authors
- Masakazu SakaiTakeshi MatsumuraMotoaki ShichiriShozo KoboriTakeshi BiwaHirofumi MatsudaSeikoh HoriuchiHideki Hakamata
- Cited by
- BiochemistryImmunologyNephrology
- Journals
- Kidney International (1 paper)Arteriosclerosis Thrombosis and Vascular Biology (2 papers)Atherosclerosis (3 papers)
- Partner nations
- Japan
In The Last Decade
Toru Takemura
11 papers receiving 322 citations
Peers
Comparison fields: 5 of 73
- Biochemistry 32
- Immunology 105
- Nephrology 26
- Cancer Research 46
- Pharmacology 23
Countries citing papers authored by Toru Takemura
This map shows the geographic impact of Toru Takemura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toru Takemura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toru Takemura more than expected).
Fields of papers citing papers by Toru Takemura
This network shows the impact of papers produced by Toru Takemura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toru Takemura. The network helps show where Toru Takemura may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Toru Takemura, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 41 | |
| 2 | [Treatment of adynamic bone disease with the complete replacement from calcium carbonate to sevelamer hydrochloride]. | 2005 | 2 |
| 3 | 2003 | 1 | |
| 4 | 2000 | 10 | |
| 5 | 2000 | 3 | |
| 6 | 1999 | 29 | |
| 7 | 1998 | 57 | |
| 8 | 1997 | 77 | |
| 9 | 1997 | 14 | |
| 10 | 1997 | 93 | |
| 11 | 1990 | 6 |
About Toru Takemura
Toru Takemura is a scholar working on Nephrology, Biochemistry and Immunology, having authored 11 papers that have together received 333 indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (2 papers), Chronic Kidney Disease and Diabetes (2 papers), Atherosclerosis and Cardiovascular Diseases (2 papers), Adipokines, Inflammation, and Metabolic Diseases (2 papers), SARS-CoV-2 and COVID-19 Research (1 paper), Influenza Virus Research Studies (1 paper), Bone health and treatments (1 paper) and Spectroscopy and Quantum Chemical Studies (1 paper). The work is most often cited by research in Biochemistry (32 citations), Immunology (105 citations) and Nephrology (26 citations). Toru Takemura has collaborated with scholars based in Japan. Frequent co-authors include Masakazu Sakai, Takeshi Matsumura, Motoaki Shichiri, Shozo Kobori, Takeshi Biwa, Hirofumi Matsuda, Seikoh Horiuchi, Hideki Hakamata, Takayuki Sasahara and Yoshihiro Sato. Their work appears in journals such as Kidney International, Arteriosclerosis Thrombosis and Vascular Biology and Atherosclerosis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.